

Is Calcipotriene still in shortage in 2026? Get the latest update on availability, pricing, and what to do if you can't find your psoriasis medication.
If you've been trying to fill your Calcipotriene prescription lately, you may have noticed something frustrating: your pharmacy doesn't have it. Maybe they said it's backordered. Maybe they couldn't give you a date for when it would be back. You're left wondering — is there a Calcipotriene shortage?
Here's what we know heading into 2026, and what you can do to make sure you stay on top of your psoriasis treatment.
As of early 2026, Calcipotriene is not listed on the FDA's official drug shortage database. That's the good news. Unlike some other medications that have been formally designated as in shortage, Calcipotriene's supply issues tend to be more localized and intermittent.
However, "not on the shortage list" doesn't mean it's easy to find everywhere. Many patients continue to report difficulty locating Calcipotriene at their local pharmacies, particularly in certain regions and for certain formulations. The cream and ointment may be harder to find than the foam or solution at times, or vice versa.
The takeaway: while there isn't an official national shortage, real-world availability can still be spotty.
Several factors contribute to Calcipotriene's inconsistent availability:
Only a handful of pharmaceutical companies produce generic Calcipotriene. When any single manufacturer pauses production — for maintenance, regulatory inspections, raw material issues, or quality control — it creates a ripple effect across the supply chain. With fewer producers, there's less backup.
The active pharmaceutical ingredients for topical medications like Calcipotriene are often sourced globally. International shipping disruptions, quality testing delays, and regulatory bottlenecks can all slow the flow of finished products to pharmacy shelves.
Calcipotriene is a niche medication — it's used almost exclusively for psoriasis. Generic manufacturers prioritize high-volume, high-demand drugs because the margins are better. A medication like Calcipotriene, with steady but moderate demand, may not get the same production priority.
Large chain pharmacies use centralized inventory systems that may not keep Calcipotriene in stock at every location. If your local branch doesn't have enough demand, they may not reorder until someone brings in a prescription — and by then, it may take days to arrive. For a deeper dive, read Why Is Calcipotriene So Hard to Find?
The cost of Calcipotriene varies widely depending on whether you have insurance, which formulation you use, and where you fill your prescription:
For detailed savings strategies, check out How to Save Money on Calcipotriene in 2026.
The psoriasis treatment landscape continues to evolve. While Calcipotriene remains a first-line topical option, newer treatments offer additional choices:
We cover all of these in more detail in Alternatives to Calcipotriene If You Can't Fill Your Prescription.
If you need Calcipotriene today, here's what to do:
For more tips, see How to Find Calcipotriene in Stock Near You.
Calcipotriene is not in a formal nationwide shortage in 2026, but that doesn't mean finding it is always easy. Limited manufacturers, supply chain challenges, and pharmacy stocking practices can all make it difficult to fill your prescription on any given day.
The key is to be proactive: use tools like Medfinder to check stock, build relationships with pharmacies that reliably carry it, and keep your prescriber in the loop so you can switch formulations or explore alternatives if needed.
Your psoriasis treatment matters, and you shouldn't have to put your health on hold because of a supply hiccup.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.